Wendy Stock to Myocardial Ischemia
This is a "connection" page, showing publications Wendy Stock has written about Myocardial Ischemia.
Connection Strength
0.018
-
A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia. Leuk Lymphoma. 2009 Dec; 50(12):1958-63.
Score: 0.018